Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we report three patients with severe deficiency of plasma low-density lipoprotein (LDL) and apo B.Two of them (probands F.A. and P.E.) had clinical and biochemical phenotype consistent with ABL.Proband F.A. was homozygous for a minute deletion/insertion (c.1228delCCCinsT) in exon 9 of MTP gene predicted to cause a truncated MTP protein of 412 amino acids.
|
15910857 |
2005 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Abetalipoproteinemia (ABL) is a recessive disorder due to mutations of microsomal triglyceride transfer protein (MTP) gene.
|
14732481 |
2004 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
These findings suggest that genetic and non-genetic factors can modulate the clinical impact of mutant MTP in ABL patients.
|
10679949 |
2000 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The rare recessive forms of primary monogenic HBL are represented by abetalipoproteinemia (ABL) and chylomicron retention disease (CMRD) due to mutations in MTP and SARA2 genes, respectively.
|
21874758 |
2011 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.
|
8533758 |
1995 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Her cousin was homozygous for 1867+1G>A MTTP mutation and presented most of the classical symptoms of ABL.
|
27578136 |
2017 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Thus, mutations in the gene for the large subunit of MTP are a cause of abetalipoproteinemia, which indicates that the MTP is a necessary component for the assembly and secretion of apoB-containing lipoproteins from the liver and intestine.
|
8044420 |
1994 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.
|
27487388 |
2016 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A search for sequence variants in the large subunit of MTP in a kindred of 10 individuals from Saguenay-Lac-St Jean area with a propositus exhibiting ABL as well as in four independent patients from the greater Quebec city area and exhibiting very low apoB and LDL-cholesterol levels identified 12 variations.
|
14741197 |
2004 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Characterization of mutations in MTP causing abetalipoproteinemia has revealed that the central α-helical and C-terminal β-sheet domains are important for protein disulfide isomerase binding and lipid transfer activity.
|
26224785 |
2015 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A novel abetalipoproteinemia genotype. Identification of a missense mutation in the 97-kDa subunit of the microsomal triglyceride transfer protein that prevents complex formation with protein disulfide isomerase.
|
8939939 |
1996 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Several mutations in the apoB, proprotein convertase subtilisin/kexin type 9 (PCSK9), and MTP genes result in low or absent levels of apoB and LDL-cholesterol in plasma, which cause familial hypobetalipoproteinemia and abetalipoproteinemia.
|
24751931 |
2014 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that genetic and non-genetic factors can modulate the clinical impact of mutant MTP in ABL patients.
|
10679949 |
2000 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.
|
23043934 |
2013 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The pigmentary retinopathy and neuropathy of abetalipoproteinemia (Mendelian Inheritance of Man 200100; Bassen-Kornzwieg disease), which is caused by mutations in the MTP gene, may involve loss of function at the retina.
|
15654125 |
2005 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We discovered a novel mutation in MTTP gene and we confirmed the diagnosis of abetalipoproteinemia in new Tunisian families.
|
23556456 |
2013 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Abetalipoproteinemia (ABL) is a rare recessive monogenic disease due to MTTP (microsomal triglyceride transfer protein) mutations leading to the absence of plasma apoB-containing lipoproteins.
|
30875496 |
2019 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
ABL and CRD are rare disorders due to mutations in the MTP and SARA2 genes, respectively.
|
17570373 |
2007 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Abetalipoproteinemia: two case reports and literature review.
|
18611256 |
2008 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Characterization of mutations in MTP causing abetalipoproteinemia has revealed that the central α-helical and C-terminal β-sheet domains are important for protein disulfide isomerase binding and lipid transfer activity.
|
26224785 |
2015 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding the 97-kDa subunit of a microsomal triglyceride transfer protein (MTP) cause ABL (Sharp, D., Blinderman, L., Combs, K. A., Klenzle, B., Ricci, B., Wager-Smith, K., Gil, C. M., Turck, C. W., Bouma, M. E., Rader, D. J., Aggerbeck, L. P., Gregg, R. E., Gordon, D. A., and Wetterau, J. R. (1993) Nature 365, 65-69; Shoulders, C. C., Brett, D. J., Bayliss, J. D., Narcisi, T. M., Jarmuz, A., Grantham, T. T., Leoni, P. R. D., Bhattacharya, S., Pease, R. J., Cullen, P. M., Levi, S., Byfield, P. G. H., Purkiss, P., and Scott, J.(1993) Hum.Mol.Genet.2, 2109-2116).
|
8071315 |
1994 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our results demonstrated that ABL SH3 mutant T79Y markedly repressed the expression of BCR-ABL signaling pathways in IM-resistant cell lines KCL22 and K562/G01 as well as IM-sensitive cell line K562.
|
26321052 |
2015 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Identification of a novel mutation of MTP gene in a patient with abetalipoproteinemia.
|
21502686 |
2011 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Using induced pluripotent stem cells (iPSCs) generated from an ABL patient homozygous for a missense mutation (MTTP<sup>R46G</sup>), we show that human hepatocytes and cardiomyocytes exhibit defects associated with ABL disease, including loss of apolipoprotein B (apoB) secretion and intracellular accumulation of lipids.
|
28514664 |
2017 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
ABL results from mutations in the MTP gene; Ho-FHBL may be due to mutations in the APOB gene.
|
19056372 |
2009 |